SE0102057D0 - New Salts I - Google Patents

New Salts I

Info

Publication number
SE0102057D0
SE0102057D0 SE0102057A SE0102057A SE0102057D0 SE 0102057 D0 SE0102057 D0 SE 0102057D0 SE 0102057 A SE0102057 A SE 0102057A SE 0102057 A SE0102057 A SE 0102057A SE 0102057 D0 SE0102057 D0 SE 0102057D0
Authority
SE
Sweden
Prior art keywords
new salts
napsylate
salts
stereoisomers
solvate
Prior art date
Application number
SE0102057A
Other languages
Swedish (sv)
Inventor
Lynne Taylor
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102057A priority Critical patent/SE0102057D0/en
Publication of SE0102057D0 publication Critical patent/SE0102057D0/en
Priority to PCT/SE2002/001083 priority patent/WO2002100869A1/en
Priority to UY27324A priority patent/UY27324A1/en

Links

Abstract

Novel napsylate salts of formula I, or a solvate thereof, (I) and stereoisomers thereof, as well as a process for the preparation thereof, pharmaceutical compositions containing the therapeutically active napsylate salt and the use of said active compounds in therapy.
SE0102057A 2001-06-08 2001-06-08 New Salts I SE0102057D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0102057A SE0102057D0 (en) 2001-06-08 2001-06-08 New Salts I
PCT/SE2002/001083 WO2002100869A1 (en) 2001-06-08 2002-06-04 New napsylate salts i
UY27324A UY27324A1 (en) 2001-06-08 2002-06-07 NEW NAPSILATE SALTS I

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102057A SE0102057D0 (en) 2001-06-08 2001-06-08 New Salts I

Publications (1)

Publication Number Publication Date
SE0102057D0 true SE0102057D0 (en) 2001-06-08

Family

ID=20284432

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102057A SE0102057D0 (en) 2001-06-08 2001-06-08 New Salts I

Country Status (3)

Country Link
SE (1) SE0102057D0 (en)
UY (1) UY27324A1 (en)
WO (1) WO2002100869A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
WO2006050471A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US20060160777A1 (en) * 2004-12-27 2006-07-20 Anders Lehmann New use of GABAbeta receptor agonists
WO2006071186A1 (en) * 2004-12-27 2006-07-06 Astrazeneca Ab Use of gabab receptor agonists
US7585996B2 (en) 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
WO2009014491A1 (en) * 2007-07-25 2009-01-29 Astrazeneca Ab The use of (3-amino-2-fluoropropyl) phosphinic acid for treatment of nerd
US20110054216A1 (en) * 2007-12-21 2011-03-03 Hassan Abbasi Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a
EP2235027A4 (en) * 2007-12-21 2011-06-22 Astrazeneca Ab Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
WO2009082348A1 (en) * 2007-12-21 2009-07-02 Astrazeneca Ab Novel crystalline form c of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
WO2012009646A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (en) * 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
WO2002100869A1 (en) 2002-12-19
UY27324A1 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
CO5271691A1 (en) NEW COMPOUNDS
TW200745111A (en) New compounds
SE0200979D0 (en) New compounds
SE9904505D0 (en) Novel compounds
DE602004024375D1 (en) carboxamide
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
SE0202463D0 (en) Novel compounds
EE200300403A (en) N-substituted Non-Aromatic Heterocyclic Compound, Pharmaceutical Composition Containing It, and Use of the Compound as a Pharmaceutical
SE9904508D0 (en) New compounds
SE9903544D0 (en) Novel compounds
BR0309343A (en) Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions.
GB0112348D0 (en) Compounds
NO20052182L (en) New connections
TW200606164A (en) New compounds
BR0309342A (en) Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions.
SE0302192D0 (en) Novel compounds
MXPA05012247A (en) New benzimidazole derivatives.
SE0100569D0 (en) New compounds
GB0109122D0 (en) Novel compounds
ATE386725T1 (en) HETEROCYCLYL COMPOUNDS
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
EA200400086A1 (en) NEW OXAZOLIDINON DERIVATIVES AS ANTIBACTERIAL AGENTS
TW200800984A (en) New compounds
SE0102055D0 (en) New Compounds
SE0300908D0 (en) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them